CoronaryAtlas logo
CoronaryAtlas
Noradrenaline
Pathway / Endothelial activation & erosion

Noradrenaline

metabolite

Noradrenaline promotes endothelial activation and dysfunction, increases platelet reactivity, and alters thrombus architecture in atherothrombotic MI.

Pathway placement
Cascade stepEndothelial activation & erosion
Confidencemedium
RationaleCatecholamine linked to endothelial damage and dysfunction; affects clot microstructure and platelet activation in STEMI.
Also acts inPlatelet activation
Druggability
Not assessed (no mapped human gene target).

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
C — confounder / Type-II
67
A — assay feasibility
42
E — evidence strength
39
T1DI (composite)
4
Specificity differential (R−C)-51.7
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationn/a
2anemia / acute blood lossmag 2
3hypovolemia / dehydrationn/a
4tachyarrhythmian/a
5hypoxemia / respiratory failuren/a
6hypertensive emergencyn/a
7high-demand / peri-operative stressn/a
Coverage: 1/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 2 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research

Literature evidence(4)

Clinical trials(1)